These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31024314)
1. Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats. Balogh M; Zádor F; Zádori ZS; Shaqura M; Király K; Mohammadzadeh A; Varga B; Lázár B; Mousa SA; Hosztafi S; Riba P; Benyhe S; Gyires K; Schäfer M; Fürst S; Al-Khrasani M Front Pharmacol; 2019; 10():347. PubMed ID: 31024314 [TBL] [Abstract][Full Text] [Related]
2. The Peripheral Versus Central Antinociception of a Novel Opioid Agonist: Acute Inflammatory Pain in Rats. Balogh M; Zádori ZS; Lázár B; Karádi D; László S; Mousa SA; Hosztafi S; Zádor F; Riba P; Schäfer M; Fürst S; Al-Khrasani M Neurochem Res; 2018 Jun; 43(6):1250-1257. PubMed ID: 29725918 [TBL] [Abstract][Full Text] [Related]
3. Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain. Khalefa BI; Mousa SA; Shaqura M; Lackó E; Hosztafi S; Riba P; Schäfer M; Ferdinandy P; Fürst S; Al-Khrasani M Eur J Pharmacol; 2013 Aug; 713(1-3):54-7. PubMed ID: 23665110 [TBL] [Abstract][Full Text] [Related]
4. A new potent analgesic agent with reduced liability to produce morphine tolerance. Kiraly K; Caputi FF; Hanuska A; Kató E; Balogh M; Köles L; Palmisano M; Riba P; Hosztafi S; Romualdi P; Candeletti S; Ferdinandy P; Fürst S; Al-Khrasani M Brain Res Bull; 2015 Aug; 117():32-8. PubMed ID: 26235542 [TBL] [Abstract][Full Text] [Related]
5. A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy. Lacko E; Varadi A; Rapavi R; Zador F; Riba P; Benyhe S; Borsodi A; Hosztafi S; Timar J; Noszal B; Furst S; Al-Khrasani M Curr Med Chem; 2012; 19(27):4699-707. PubMed ID: 22934777 [TBL] [Abstract][Full Text] [Related]
6. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids. Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491 [TBL] [Abstract][Full Text] [Related]
7. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration. Lackó E; Riba P; Giricz Z; Váradi A; Cornic L; Balogh M; Király K; Csekő K; Mousa SA; Hosztafi S; Schäfer M; Zádori ZS; Helyes Z; Ferdinandy P; Fürst S; Al-Khrasani M J Pharmacol Exp Ther; 2016 Oct; 359(1):171-81. PubMed ID: 27435180 [TBL] [Abstract][Full Text] [Related]
8. Reduced number, G protein coupling, and antinociceptive efficacy of spinal mu-opioid receptors in diabetic rats are reversed by nerve growth factor. Shaqura M; Khalefa BI; Shakibaei M; Winkler J; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M J Pain; 2013 Jul; 14(7):720-30. PubMed ID: 23623572 [TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Chen SR; Pan HL Anesthesiology; 2003 Dec; 99(6):1409-14. PubMed ID: 14639157 [TBL] [Abstract][Full Text] [Related]
10. Contribution of G-Protein α-Subunits to Analgesia, Hyperalgesia, and Hyperalgesic Priming Induced by Subanalgesic and Analgesic Doses of Fentanyl and Morphine. Araldi D; Bonet IJM; Green PG; Levine JD J Neurosci; 2022 Feb; 42(7):1196-1210. PubMed ID: 34965973 [TBL] [Abstract][Full Text] [Related]
11. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia. Sun J; Chen SR; Chen H; Pan HL J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671 [TBL] [Abstract][Full Text] [Related]
12. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264 [TBL] [Abstract][Full Text] [Related]
13. Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats. Obara I; Gunduz Cinar O; Starowicz K; Benyhe S; Borsodi A; Przewlocka B J Neural Transm (Vienna); 2010 Apr; 117(4):421-9. PubMed ID: 20213428 [TBL] [Abstract][Full Text] [Related]
14. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids. Chen SR; Pan HL Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888 [TBL] [Abstract][Full Text] [Related]
15. Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats. Zurek JR; Nadeson R; Goodchild CS Pain; 2001 Feb; 90(1-2):57-63. PubMed ID: 11166970 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats. Hashimoto T; Saito Y; Yamada K; Hara N; Kirihara Y; Tsuchiya M Anesthesiology; 2006 Sep; 105(3):574-80. PubMed ID: 16931992 [TBL] [Abstract][Full Text] [Related]
17. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia. Chen SR; Pan HL J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418 [TBL] [Abstract][Full Text] [Related]
18. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn. Wang D; Chen T; Zhou X; Couture R; Hong Y Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038 [TBL] [Abstract][Full Text] [Related]
19. 14-O-Methylmorphine: A Novel Selective Mu-Opioid Receptor Agonist with High Efficacy and Affinity. Zádor F; Balogh M; Váradi A; Zádori ZS; Király K; Szűcs E; Varga B; Lázár B; Hosztafi S; Riba P; Benyhe S; Fürst S; Al-Khrasani M Eur J Pharmacol; 2017 Nov; 814():264-273. PubMed ID: 28864212 [TBL] [Abstract][Full Text] [Related]
20. Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice. Christoph T; Schröder W; Tallarida RJ; De Vry J; Tzschentke TM J Pharmacol Exp Ther; 2013 Dec; 347(3):794-801. PubMed ID: 24051022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]